版本:
中国

BRIEF-Immunovaccine announces $10 million bought deal offering

May 31 Immunovaccine Inc:

* Immunovaccine announces $10 million bought deal offering

* Immunovaccine Inc says intends to use net proceeds of offering to advance company's various depovax™-based products clinical studies

* Immunovaccine Inc - entered into a bought deal financing agreement to sell 7.7 million common shares of corporation at a price of $1.30 per common share

* Immunovaccine Inc - offering is expected to close on or about June 21, 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐